CEO of API and Services division resigns, effective Nov 12 2026

Key managerial personnel resignedManagement Changes View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹1206.70

prior close

₹1205.90

announcement price

After-mkt

timing

Nifty 100market-0.2%-0.4% vs market

Pharmaceuticals peers, median of 166sector-0.4%-0.1% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty 100 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.4

15m

-0.6

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-0.2-0.4-0.4-0.1

Next day

-1.2-0.4-0.8-0.3-0.9

-2.3-0.9-1.4-0.5-1.8

-3.0-1.3-1.8-1.3-1.7

-2.2-0.7-1.5-0.8-1.4

-2.7-0.7-2.0-0.4-2.3

-1.1-0.3-0.8-0.9-0.2

15d

-4.6-2.1-2.5+0.0-4.7

-5.1-5.4+0.3-0.1-5.0

+0.8-7.3+8.1-2.8+3.6

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Deepak Sapra, CEO of API and Services and Senior Management Personnel, has resigned from Dr Reddys Laboratories to pursue opportunities outside the company. Effective close of business hours on November 12, 2026. He has spent 23 plus years with the company since 2003 and will support a smooth transition during the notice period.

Likely market impact

Loss of a long-tenured leader heading the API and Services segment; investors may watch for succession plans and continuity of the division.